Drugs / TROMETHAMINE
TROMETHAMINE
also known as
NSC-6365 · Tham · Tris-base · Tris-hydroxymethyl Aminomethane · Trizma · Tromethamine component of tham-e
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03078088 | Jun 2017 → Feb 2019 | cystic fibrosis | Lakshmi Durairaj | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07424625 | Sep 2026 → Dec 2027 expected | metabolic acidosis | Mayo Clinic | Recruiting | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TROMETHAMINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200391 ↗ |
| Known as | NSC-6365 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200391 ↗ |
| Known as | Tham | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03078088 ↗ |
| Known as | Tris-base | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200391 ↗ |
| Known as | Tris-hydroxymethyl Aminomethane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07424625 ↗ |
| Known as | Trizma | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200391 ↗ |
| Known as | Tromethamine component of tham-e | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200391 ↗ |
| Modality | Small molecule | — CHEMBL1200391 ↗ |